Genetics of Retinoblastoma

Area of Science:

• Ophthalmology
• Genetics
• Pediatric Oncology

Background:

• Retinoblastoma is a malignant pediatric retinal tumor caused by mutations in the RB1 gene.
• Tumorigenesis requires biallelic RB1 gene inactivation, with one mutation potentially inherited (germline) and the second acquired (somatic).
• Distinguishing between germline and somatic mutations is key for patient management.

Purpose of the Study:

• To discuss the clinical significance of genetic testing and counseling for retinoblastoma.
• To highlight the importance of identifying RB1 germline status in affected children.
• To inform prognosis and surveillance strategies based on genetic findings.

Main Methods:

• Review of clinical aspects of genetic testing for retinoblastoma.
• Discussion of genetic counseling principles for families with retinoblastoma.
• Analysis of the impact of RB1 germline status on patient outcomes.

Main Results:

• Identification of germline RB1 mutations allows classification into heritable or sporadic retinoblastoma.
• Germline status impacts risk assessment for subsequent tumors (ocular and nonocular).
• Genetic information guides personalized surveillance protocols.

Conclusions:

• Genetic testing and counseling are essential for comprehensive retinoblastoma care.
• Understanding germline status is vital for accurate prognosis and risk stratification.
• This knowledge supports tailored surveillance strategies to improve outcomes for affected children.